RELIABLE BIOPHARMACEUTICAL, LLC
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 09, 2016 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 63 Total Citation Count
- Mar 30, 1993 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9255119 Process for perparing fondaparinux sodium and intermediates useful in the synthesis thereofApr 18, 14Feb 09, 16[C07H, A61K, C07G, C08B]
8987430 Efficient and scalable process for the manufacture of fondaparinux sodiumMar 08, 13Mar 24, 15[C07H]
8859522 Processes for the preparation of regadenoson and a new crystalline form thereofApr 26, 12Oct 14, 14[C07H]
8703923 Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereofSep 14, 12Apr 22, 14[C07H, C07G]
8420790 Efficient and scalable process for the manufacture of Fondaparinux sodiumOct 29, 10Apr 16, 13[C07H]
8288515 Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereofJul 30, 10Oct 16, 12[C08B]
7393954 Process for the production of pentostatin aglycone and pentostatinDec 12, 03Jul 01, 08[C07D]
6252061 Process for the production of 2-halo-6-aminopurine derivativesMar 23, 99Jun 26, 01[C07H, C07D]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.